Detecting Occult Malignancy in Prophylactic Mastectomy: Preoperative MRI Versus Sentinel Lymph Node Biopsy

[1]  H. Thaler,et al.  Sensory morbidity after sentinel lymph node biopsy and axillary dissection: A prospective study of 233 women , 2002, Annals of Surgical Oncology.

[2]  D. Fraker,et al.  Magnetic resonance imaging-guided biopsy of mammographically and clinically occult breast lesions , 2007, Annals of Surgical Oncology.

[3]  S. Singletary,et al.  Selective use of sentinel lymph node surgery during prophylactic mastectomy , 2006, Cancer.

[4]  Sheryl G. A. Gabram,et al.  Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial , 2006, Annals of Surgical Oncology.

[5]  Michael J. Miller,et al.  Rationale for elective contralateral Mastectomy with immediate bilateral reconstruction , 1994, Annals of Surgical Oncology.

[6]  W. Gillanders,et al.  Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: Experience in patients undergoing prophylactic mastectomy , 2005 .

[7]  H. D. de Koning,et al.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. , 2004, The New England journal of medicine.

[8]  Susan L Neuhausen,et al.  Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Mitchell D Schnall,et al.  MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. , 2003, Radiology.

[10]  Jennifer B Kaplan,et al.  MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. , 2003, AJR. American journal of roentgenology.

[11]  L. Kiemeney,et al.  High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Susan L Neuhausen,et al.  Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.

[13]  P. Chappuis,et al.  Re: Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. , 2001, Journal of the National Cancer Institute.

[14]  T. Sellers,et al.  Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J O Barentsz,et al.  Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. , 2001, Journal of the National Cancer Institute.

[16]  S. Dobie,et al.  Prophylactic mastectomy for prevention of breast cancer. , 1999, The Journal of family practice.

[17]  D J Schaid,et al.  Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. , 1999, The New England journal of medicine.